NDC 63323-294-01 - Polocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-294
- Requested NDC
- 63323-294-01
- Package NDCs from labels
- 63323-294-01, 63323-294-27
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2022-10-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Polocaine - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2022-10-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-294-01 | Polocaine-MPF | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 5 | |
| 63323-294-27 | Polocaine-MPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-294 | POLOCAINE (MEPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION POLOCAINE-MPF (MEPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 2 package rows | 20221009_a27d0815-ae6b-4a21-a8f5-564c01e83814.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-294-01 | ML - Milliliter | 63323-294 | ffbc23f4-3877-4b3a-935d-83e5e93b539a | 1 | 2021-03-02 |
| 63323-294-20 | ML - Milliliter | 63323-294 | 764678df-3057-4c14-bfbe-3e3d56298ccc | 1 | 2012-07-24 |
| 63323-294-27 | ML - Milliliter | 63323-294 | 56e3897e-2eff-4322-9354-8c266a55a85d | 1 | 2018-03-08 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Carbocaine | MEPIVACAINE HYDROCHLORIDE | Septodont, Inc. | 1f2f9e40-e437-4124-97b7-df67dbafd154 | 2024-02-21 | Warnings, Adverse reactions | 4VFX2L7EM5 |
| Polocaine | MEPIVACAINE HYDROCHLORIDE | Novocol Pharmaceutical of Canada Inc. | eb7e2284-fe8d-46ad-b1d3-92ee2c6222bf | 2024-02-21 | Warnings, Adverse reactions | 4VFX2L7EM5 |
| Mepivacaine | MEPIVACAINE HYDROCHLORIDE | Benco Dental | c9a5a849-d010-4637-a66a-c26176401fbd | 2024-02-21 | Warnings, Adverse reactions | 4VFX2L7EM5 |
| Mepivacaine | MEPIVACAINE HYDROCHLORIDE | NDC, Inc. | 042010fb-7161-4336-b91f-5a25839ee644 | 2024-02-21 | Warnings, Adverse reactions | 4VFX2L7EM5 |
| Mepivacaine | MEPIVACAINE HYDROCHLORIDE | Patterson Dental Supply, Inc. | e8a3df4b-e918-4813-af3e-3c95f2c54250 | 2024-02-21 | Warnings, Adverse reactions | 4VFX2L7EM5 |
| Polocaine | MEPIVACAINE HYDROCHLORIDE | Dentsply Pharmaceutical | 25074a6a-7f67-4ad8-86e0-2afe23ec5d04 | 2024-02-21 | Warnings, Adverse reactions | 4VFX2L7EM5 |
| Bladder Relief | CAUSTICUM, NATRUM MURIATICUM, NUX VOMICA, PULSATILLA (VULGARIS), SEPIA, STAPHYSAGRIA, THUJA OCCIDENTALIS | The Magni Company | b09bf037-703f-4c22-8535-b33d586ebefa | 2024-02-08 | Warnings | 451W47IQ8X |
| Potassium Chloride | POTASSIUM CHLORIDE | Proficient Rx LP | 61daa681-05a0-4b2f-a6d0-c6fc1044f521 | 2024-02-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Ear Ringing | ACONITUM NAP., BARYTA CARB., BARYTA MUR., CAPSICUM, CAUSTICUM, CHENOPODIUM ANTHELMINTICUM, CHININUM SULPHURICUM, CINCHONA, GLONOINUM, GRAPHITES, HYDRASTIS, KALI BIC., KALI MUR., LYCOPODIUM, PHOSPHORUS, PULSATILLA, SALICYLICUM AC., TABACUM, THIOSINAMINUM, VIOLA ODORATA | Newton Laboratories, Inc. | 1043debe-8787-a2f5-e063-6294a90a2a66 | 2024-01-31 | Warnings | 660YQ98I10 |
| Ear Ringing | ACONITUM NAP., BARYTA CARB., BARYTA MUR., CAPSICUM, CAUSTICUM, CHENOPODIUM ANTHELMINTICUM, CHININUM SULPHURICUM, CINCHONA, GLONOINUM, GRAPHITES, HYDRASTIS, KALI BIC., KALI MUR., LYCOPODIUM, PHOSPHORUS, PULSATILLA, SALICYLICUM AC., TABACUM, THIOSINAMINUM, VIOLA ODORATA | Newton Laboratories, Inc. | 1045ab27-c4d5-fcbd-e063-6294a90a5176 | 2024-01-31 | Warnings | 660YQ98I10 |
| Tinnitus | ACONITUM NAP., BARYTA CARB., BARYTA MUR., CAPSICUM, CAUSTICUM, CHENOPODIUM ANTHELMINTICUM, CHININUM SULPHURICUM, CINCHONA, GLONOINUM, GRAPHITES, HYDRASTIS, KALI BIC., KALI MUR., LYCOPODIUM, PHOSPHORUS, PULSATILLA, SALICYLICUM AC., TABACUM, THIOSINAMINUM, VIOLA ODORATA | Newton Laboratories, Inc. | 10462aaa-96d4-4ba3-e063-6294a90a7915 | 2024-01-31 | Warnings | 660YQ98I10 |
| Natrum Muriaticum | SODIUM CHLORIDE | SEVENE USA | 11008014-fff6-4d5a-8c5c-a20443d7cc23 | 2024-01-30 | Warnings | 451W47IQ8X |
| POLOCAINE (MEPIVACAINE HCl) | POLOCAINE (MEPIVACAINE HCL) | HF Acquisition Co LLC, DBA HealthFirst | c21a4c3a-82c0-0bfb-e053-2995a90a2b65 | 2024-01-30 | Warnings, Adverse reactions | ANDA089407 1012722 4VFX2L7EM5 |
| POLOCAINE (MEPIVACAINE HCl) | POLOCAINE (MEPIVACAINE HCL) | HF Acquisition Co LLC, DBA HealthFirst | c20406a6-5611-59e4-e053-2995a90a3c8f | 2024-01-30 | Warnings, Adverse reactions | ANDA089410 1012737 4VFX2L7EM5 |
| Potassium Chloride | POTASSIUM CHLORIDE | Lupin Pharmaceuticals,Inc. | fe08221d-74d5-490a-8db4-eaf3ed20b289 | 2024-01-30 | Warnings, Adverse reactions | 660YQ98I10 |
| POLOCAINE(R) -MPF (MEPIVACAINE HCI) | POLOCAINE(R) -MPF (MEPIVACAINE HCI) | HF Acquisition Co LLC, DBA HealthFirst | 996381e2-485b-9434-e053-2a95a90a08e1 | 2024-01-29 | Warnings, Adverse reactions | ANDA089406 1866503 4VFX2L7EM5 |
| CALCIUM CHLORIDE | CALCIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 75c43df8-24f4-7f26-e053-2a91aa0aa21b | 2024-01-29 | Warnings, Adverse reactions | M4I0D6VV5M |
| LACTATED RINGERS | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | a14ca7d9-de30-a303-e053-2a95a90a5304 | 2024-01-27 | Warnings, Adverse reactions | 451W47IQ8X 660YQ98I10 M4I0D6VV5M |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | e5247ed5-6170-c13f-e053-2a95a90a4101 | 2024-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| CALCIUM CHLORIDE | CALCIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 994a17da-4430-9489-e053-2a95a90acb7c | 2024-01-27 | Warnings, Adverse reactions | M4I0D6VV5M |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.